| Literature DB >> 31412655 |
Youness Frichi1, Fouad Jawab2,3, Said Boutahari2.
Abstract
(1) Background: Quality of care (QC) is not only about satisfying patients, but also about satisfying the various health system stakeholders (HSS). This makes it a complex and difficult objective to achieve. This study aims at proposing a methodological framework for identifying HSS, prioritizing them in QC, and analyzing their interrelationships. (2)Entities:
Keywords: 5W; DEMATEL; Delphi; health system; quality of care; stakeholders
Mesh:
Year: 2019 PMID: 31412655 PMCID: PMC6719162 DOI: 10.3390/ijerph16162899
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Dimensions of quality of care.
| Dimension | Definition | Observable Indicators |
|---|---|---|
| (1) Effectiveness | Health care is based on current scientific knowledge and provided to those in need. |
Healthcare is based on current scientific knowledge (compliance with standards, compliance with recommendations, etc.). Healthcare is provided to those who need it (targeting). Healthcare achieves the desired outcomes. |
| (2) Safety | The extent to which health care processes avoid and prevent adverse events. |
Healthcare is provided in a way that reduces the occurrence of sentinel events (transfusion-related accidents, surgery on the wrong person, forgetting foreign objects in the patient’s body, etc.). Measures are taken to minimize surgical and post-operative complications. Healthcare is provided in a way that prevents the acquisition of nosocomial infections. |
| (3) Efficiency | Health care is produced with optimal use of available resources to achieve the best results. |
Resources are used in a rational way. Activities with no added value are reduced to the minimum or even eliminated. Waste is reduced by effective recycling. |
| (4) Accessibility | The availability of healthcare services and the ease with which they are reached (physical, financial, psychological accessibility). |
Medical resources are available. Difficulties of geographical access to healthcare are reduced. The burden to healthcare costs are reduced. The time allocated to making appointments and waiting for care is short. |
| (5) Patient-leftedness | The extent to which healthcare delivery takes into account patient preferences, values and choices. |
Patients are informed about their health conditions. Patients have the opportunity to communicate with their doctors. Patients are involved in decision-making processes. Healthcare is provided with respect for patients, their preferences and cultures. Healthcare is coordinated and integrated (patient transitions between care units and between health facilities are managed effectively). |
| (6) Equity | Services quality does not vary because of patients’ personal characteristics such as gender, ethnicity, geographical location and socio-economic status. |
The health system guarantees services to the entire population. Disparities in the provision of healthcare between groups in society are very small or even absent (rich/poor, rural/urban areas, etc.). Healthcare services are provided according to patients’ needs and not to their personal characteristics. |
Figure 1Methodological framework 5W2D for health system stakeholders (HSS) analysis.
Figure 2Grid for prioritizing HSS in QC.
Figure 3Steps to implement the Decision making trial and evaluation laboratory (DEMATEL) technique.
Figure 4The paper selection process.
Selected publications on HSS.
|
|
|
|
|
| [ | Examine stakeholders’ roles to facilitate access to essential medicines. | Australia |
Government: ministries of health, education, transport, agriculture, industry, etc. Political parties Local authorities Regional and provincial directorates of ministries in charge of health, education, transport, etc. Health personnel: physicians, nurses, pharmacists, etc. Health personnel representatives: trade unions, etc. Patients and their families Patient advocates Health insurance bodies Non-governmental organizations and the not-for-profit sector United Nations agencies Health facilities Healthcare industry and professional associations: product suppliers (drugs, equipment, software, etc.) subcontractors (transportation, food service, etc.) Health researchers: universities, laboratories, learned societies, etc. Shareholders (for private healthcare facilities) Employers Media |
| [ | Mapping challenges related to the adoption of Artificial Intelligence in the public health sector. | China | |
| [ | Exploring stakeholders’ perspectives on public-private partnership in health service delivery in the Pakistani context. | Pakistan | |
| [ | Studying the feasibility of integrating traditional birth attendants into maternal mental healthcare. | Kenya | |
| [ | Examine the openness of health policies in terms of integrating the employees voice. | England | |
| [ | Analysis of stakeholders’ views on proposed solutions to improve the performance of the Quebec health system. | Canada | |
| [ | Proposition of a framework to guide the collection, planning of the implementation and use of Patient-Reported Outcome Measures. | USA | |
| [ | Identification of barriers and strategies for implementing psychological interventions for older adults with cancer. | USA | |
| [ | Modeling the nurse-to-patient assignment problem in home care under continuity of care while taking into consideration stakeholders’ perspectives. | Italy | |
| [ | Discussing risks and legal implications of using modern telemedicine systems. | Italy | |
| [ | Formulation and prioritization of strategies for the implementation of Shared Decision Making, based on the identification of obstacles to change. | Netherlands | |
| [ | Establishment of guidelines for the development of radiation oncology nomenclature for clinical trials, data sharing initiatives, and population-based studies. | USA | |
| [ | Description of a blueprint for the use of participatory design in the design of community pharmacy interventions. | USA | |
| [ | Identification of challenges and opportunities for the implementation of regional health systems. | Singapore | |
| [ | Analysis of health information technology safety assurance practices. | England | |
| [ | Stakeholder analysis to identify a planning group for the development of community pharmacy service to prevent cardiovascular disease. | Australia | |
| [ | Development of an innovative system of structured incentives model in an academic health sciences center, linking distribution of government payments to quality and performance outcomes. | Canada | |
| [ | Identification of challenges in the implementation of non-invasive prenatal testing for fetal aneuploidy. | Netherlands | |
| [ | Identification of factors promoting or hindering the sustainability of the implementation of knowledge implementation strategies in low- and middle-income contexts. | Vietnam | |
| [ | Analysis of stakeholders’ opinions on the benefits and risks of data sharing in multicenter comparative efficacy research studies. | USA | |
| [ | Studying stakeholders’ understanding of engagement in care improvement initiatives. | Canada | |
| [ | Evaluation of the value and potential of drug repositioning. | European Union | |
| [ | Analysis of stakeholders’ opinions on the Redispensing of medicines unused by patients, and their reuse by other patients. | Netherlands | |
| [ | Engaging stakeholders to adapt patient-centered home care tenets for veterans to the needs of women veterans. | USA | |
| [ | Identification of key determinants of practice influencing the implementation of community pharmacy services in the primary care network. | Australia | |
| [ | Identification of the main problems and potential solutions to the implementation of national strategies for childhood cancer in Latin America. | Latin America | |
| [ | Improving coordination between health care facilities in patient transition by identifying factors that lead to poor clinical outcomes. | USA | |
| [ | Analysis of the views of different stakeholders on public engagement in the reconfiguration of emergency care systems. | Ireland | |
| [ | Description of the current status of the use of electronic personal health records and identification of facilitators and barriers to their adoption. | Canada | |
| [ | Analyzing stakeholder perspectives and participation in the health system change process that led to the introduction of the first Nurse Practitioner-Led clinics in Ontario. | Canada | |
| [ | Analysis of stakeholders’ views on the European Union’s cross-border healthcare directive. | European Union | |
| [ | Determination of the health benefits package to be included in universal health coverage that is acceptable and sustainable to stakeholders. | Lebanon | |
| [ | Identification and prioritization of gaps between current scientific evidence and the actual care provided, as well as opportunities to improve the QC. | Canada | |
| [ | Discussion and analysis of the reform on the organization, financing and planning of medical workforce education in England during the Conservative and Liberal Democrat coalition government’s time in office. | England | |
| [ | Establishment of a comprehensive set of design requirements for digital reablement system to increase the home autonomy of older people. | England | |
| [ | Proposal and development of a decentralized information system for collaboration purposes linking medical providers, paramedical providers and patients for personalized quality services. | Greece | |
| [ | Understanding and analyzing facilitators and barriers to the adoption and use of clinical information systems in intensive care units. | USA | |
| [ | Understanding and examining the manner in which function the networks managing health-care waste. | Palestine |
Identification of HSS in Morocco.
| What | ||
|---|---|---|
| Identification of Organizations, Institutions, Individuals and Groups of Individuals Who Have an Influence or are Influenced by Health System Actions in Morocco. | ||
| Who | Why | Where |
| Government: Ministries of Health, Economy and Finance, Interior, National Defense, Transport, Education, Agriculture, etc. | Responsible for the development and implementation of national health strategies. It defines the budget allocated to the implementation of health programs and ensures its monitoring and control. The government is accountable for opening up the isolated rural areas through its policies of road network development and transportation. It is also responsible for education and scientific research development strategies. | Strategic |
| Parliament | It is the legislative institution that passes laws, oversees government actions, and evaluates public policies, particularly those related to the health sector. | Strategic |
| Regional and Provincial Directorates of Ministries | Responsible for the implementation of national policies in their territories. | Tactical |
| Local authorities: Regions, Wilayas, prefectures, provinces and municipalities | Participate in the regional and local implementation of national policies and strategies in the health, education, and transportation sectors, etc. They ensure the diagnosis of health and hygiene needs and the maintenance of rural roads. They also manage urban transportation, patients and deceased transportation, etc. | Tactical and operational |
| Public and private healthcare facilities: Basic health care centers network, hospital networks, hospital clinics, hemodialysis centers, laboratories, pharmacies, etc. | Provide preventive, curative and promotional care services (consultations, nursing care, chronic disease follow-up, etc.). They also contribute to medical and pharmaceutical training activities. | Operational |
| Health insurance bodies: National Agency of Health Insurance (NAHI), Moroccan Health Insurance Fund (MHIF), National Fund for Social Security (NFSS), private supplementary health insurance companies. | The NAHI ensures the proper functioning of the medical coverage system by providing technical support for the obligatory health insurance. It also manages the regime of medical aid to poor populations. The MHIF manages the obligatory health insurance for civil servants and students. The NFSS manages the obligatory health insurance for employees of private enterprises and self-employed persons. | Strategic, tactical, and operational |
| Training and research institutions: Universities, Faculties of Medicine and Pharmacy, Health Career Training Institutes, National School of Public Health, Pasteur Institute of Morocco, Learned societies, etc. | Provide initial and in-service training in various medical, managerial and technical disciplines. They also develop research in health sciences. | Tactical and operational |
| International health organizations: WHO, UNICEF, UNAIDS, World Bank, etc. | Provide technical and financial assistance to the State for the development of health policies and the implementation of related programs. | Strategic |
| Patients and their families | Patients are the beneficiaries of healthcare services, but also any person acting on their behalf, in particular their families. | Operational |
| Patient advocates: consumer protection associations. | Promote consumers’ right to have access to clear, objective and fair information in particular with regard to service prices and safety. | Tactical and operational |
| Civil society organizations: NGOs and private not-for-profit entities working in the health field. | Help to reach disadvantaged populations and raise awareness of public health issues. | Tactical and operational |
| Health personnel: physicians, biologists, pharmacists, dentists, nurses, medical assistants, and administrative staff | Physicians are responsible, each within their respective areas of competence, for diagnosis and care, supervision of trainee physicians, prevention and health education. Nurses carry out medical prescriptions, provide nursing care and prepare the necessary equipment and products for medical analysis and care. The administrative staff is responsible for the management of administrative affairs. | Operational |
| Health personnel representatives: Order of Physicians, Order of Dentists, Order of Pharmacists, Trade unions, etc. | Professional Orders represent the medical professions vis-a-vis the government, participate in the development and implementation of health policy and defend the moral and professional interests of the medical/pharmaceutical profession. Trade unions protect the economic, industrial, commercial and professional interests of their members. | Tactical and operational |
| National consultation institutions: Economic, Social and Environmental Council (ESEC), National Observatory for Human Development (NOHD), National Human Rights Council (NHRC), etc. | The ESEC provides advisory services to the government on social and environmental policies. The NOHD analyses and evaluates the impact of human development programs. The NHRC sees to the observation, surveillance and monitoring of human rights. | Strategic |
| Healthcare industry: manufacturers, wholesalers, distributors and subcontractors | Responsible for product development, production, and distribution. They provide healthcare facilities with goods (medicines, medical supplies, equipment, etc.) and services (IT, maintenance, food services, cleaning, etc.), that are necessary for their operations and the production of care. | Tactical and operational |
| Employers | Provide workers with a healthy and safe working environment. They are responsible for implementing appropriate environmental and health protection measures against pollution generated by industrial activities. | Operational |
| Media | Contribute to the promotion of health information and public awareness. | Tactical and operational |
Experts included in the Delphi survey.
| N° | Affiliation | Position | Years of Experience | Degree | City |
|---|---|---|---|---|---|
| 1 | Regional Hospital | Quality manager | 13 | Doctor | Fez |
| 2 | Head of Medical Affairs Department | 17 | Doctor | Fez | |
| 3 | Administrator | 10 | Master | Fez | |
| 4 | Quality manager | 10 | Maser | Tangier | |
| 5 | Purchasing manager | 16 | Master | Fez | |
| 6 | Head of the Nursing Care Unit | 10 | Technician | Fez | |
| 7 | Ministry of Health | Administrator | 12 | Master | Rabat |
| 8 | University | Health researcher | 10 | Doctor | Casablanca |
| 9 | Health researcher | 11 | Doctor | Tangier | |
| 10 | Moroccan Association for Consumer Protection and Guidance | Member of the Association | 13 | Master | Kenitra |
| 11 | University Hospital | Head of Performance Evaluation Department | 24 | Master | Rabat |
| 12 | Prefectural Hospital | Quality manager | 15 | Doctor | Casablanca |
| 13 | Pasteur Institute | Health researcher | 11 | Doctor | Casablanca |
| 14 | Regional Oncology Centre | Administrator | 12 | Master | Meknes |
| 15 | Head of Medical Affairs Department | 23 | Doctor | Meknes | |
| 16 | Administrator | 12 | Master | Meknes |
Results of the three Delphi rounds of HSS prioritization.
| HSS | Influence on QC | Impact by QC | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| First Round | Second Round | Third Round | First Round | Second Round | Third Round | |||||||
| Mean( | Standard Deviation | Mean( | Standard Deviation | Mean( | Standard Deviation | Mean( | Standard Deviation | Mean( | Standard Deviation | Mean( | Standard Deviation | |
| HSS1: Government | 25.25 | 4.18 | 25.33 | 3.27 | 26.13 | 2.80 | 22.83 | 3.46 | 23.83 | 3.04 | 23.20 | 2.73 |
| HSS2: Parliament | 18.58 | 3.40 | 17.13 | 3.31 | 16.80 | 1.90 | 15.25 | 6.22 | 16.67 | 4.42 | 15.07 | 4.82 |
| HSS3: Regional and Provincial Directorates of Ministries of Health, Transport, Interior, etc. | 22.33 | 3.20 | 22.53 | 2.56 | 21.80 | 2.18 | 19.67 | 4.19 | 20.33 | 4.01 | 20.13 | 3.60 |
| HSS4: Local authorities | 16.17 | 2.92 | 16.00 | 1.51 | 16.00 | 1.51 | 14.17 | 5.25 | 15.17 | 3.30 | 13.87 | 4.60 |
| HSS5: Public and private healthcare facilities | 19.00 | 2.95 | 19.53 | 2.59 | 19.47 | 2.00 | 20.75 | 4.45 | 20.08 | 3.50 | 20.67 | 3.44 |
| HSS6: Health insurance bodies | 17.50 | 3.18 | 17.93 | 1.94 | 18.27 | 1.75 | 19.00 | 4.16 | 18.42 | 3.65 | 18.00 | 3.27 |
| HSS7: Training and research institutions | 17.33 | 3.17 | 17.80 | 1.70 | 17.47 | 1.81 | 13.42 | 4.34 | 13.33 | 4.12 | 12.87 | 3.83 |
| HSS8: International health organizations | 20.00 | 3.64 | 18.67 | 2.35 | 18.27 | 2.09 | 16.25 | 4.94 | 16.00 | 4.71 | 15.00 | 3.72 |
| HSS9: Patients and their families | 21.92 | 3.94 | 19.87 | 2.26 | 20.60 | 2.23 | 26.83 | 2.92 | 27.92 | 2.43 | 27.80 | 2.31 |
| HSS10: Patient advocates | 20.00 | 2.95 | 17.33 | 2.87 | 19.07 | 1.71 | 15.50 | 2.94 | 14.75 | 2.18 | 15.80 | 2.04 |
| HSS11: Civil society organizations | 18.33 | 2.10 | 18.00 | 1.46 | 18.00 | 1.46 | 14.17 | 4.45 | 14.92 | 4.25 | 14.93 | 3.47 |
| HSS12: Health personnel | 26.42 | 3.82 | 25.73 | 2.94 | 26.53 | 2.80 | 21.50 | 4.42 | 23.92 | 4.52 | 23.60 | 3.87 |
| HSS13: Health personnel representatives | 18.75 | 3.02 | 17.53 | 2.20 | 17.53 | 2.20 | 17.00 | 3.79 | 17.67 | 3.20 | 16.80 | 2.86 |
| HSS14: Employers | 14.00 | 3.16 | 13.40 | 1.96 | 12.87 | 1.92 | 12.00 | 4.00 | 11.50 | 3.21 | 11.07 | 2.81 |
| HSS15: Healthcare industry | 17.08 | 2.75 | 16.80 | 2.01 | 16.93 | 2.02 | 13.00 | 2.63 | 13.25 | 2.30 | 12.73 | 2.22 |
| HSS16: National consultation institutions | 14.83 | 3.97 | 13.80 | 2.54 | 13.80 | 2.54 | 11.17 | 4.34 | 11.00 | 4.11 | 10.53 | 3.66 |
| HSS17: Media | 16.50 | 3.61 | 16.27 | 2.22 | 16.27 | 2.12 | 9.58 | 4.25 | 9.42 | 3.82 | 9.33 | 3.22 |
| Kendall’s | 0.468 | 0.626 | 0.705 | 0.560 | 0.665 | 0.708 | ||||||
Figure 5Positions of HSS according to their influence on and impact by QC.
Direct-relation average matrix D.
| HSS1 | HSS2 | HSS3 | HSS4 | HSS5 | HSS6 | HSS7 | HSS8 | HSS9 | HSS10 | HSS11 | HSS12 | HSS13, | HSS14 | HSS15 | HSS16, | HSS17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HSS1 | 0.0000 | 0.6667 | 4.0000 | 2.0000 | 3.0000 | 3.0000 | 3.6667 | 1.3333 | 4.0000 | 1.3333 | 2.3333 | 4.0000 | 2.6667 | 3.3333 | 3.0000 | 0.6667 | 2.0000 |
| HSS2 | 2.3333 | 0.0000 | 0.6667 | 1.3333 | 1.0000 | 0.6667 | 0.6667 | 0.3333 | 1.6667 | 1.6667 | 1.3333 | 1.6667 | 1.0000 | 2.0000 | 0.6667 | 1.3333 | 0.3333 |
| HSS3 | 0.6667 | 0.0000 | 0.0000 | 0.6667 | 4.0000 | 0.0000 | 1.3333 | 0.3333 | 4.0000 | 0.3333 | 1.0000 | 2.6667 | 0.6667 | 0.0000 | 1.6667 | 0.0000 | 0.3333 |
| HSS4 | 0.3333 | 0.0000 | 1.3333 | 0.0000 | 0.6667 | 0.0000 | 0.3333 | 0.0000 | 3.6667 | 0.0000 | 1.3333 | 0.6667 | 0.0000 | 1.0000 | 0.0000 | 0.0000 | 0.3333 |
| HSS5 | 0.6667 | 0.0000 | 1.3333 | 0.3333 | 0.0000 | 1.3333 | 2.0000 | 1.6667 | 4.0000 | 0.3333 | 0.6667 | 4.0000 | 1.6667 | 0.0000 | 2.0000 | 0.0000 | 0.6667 |
| HSS6 | 0.3333 | 0.0000 | 0.0000 | 0.0000 | 1.0000 | 0.0000 | 0.0000 | 0.6667 | 4.0000 | 0.0000 | 0.0000 | 0.3333 | 0.3333 | 0.0000 | 2.6667 | 0.0000 | 0.0000 |
| HSS7 | 0.6667 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.3333 | 0.0000 | 1.6667 | 3.6667 | 0.0000 | 0.0000 | 1.3333 | 0.3333 | 0.0000 | 2.3333 | 0.0000 | 0.0000 |
| HSS8 | 2.6667 | 0.3333 | 1.3333 | 0.3333 | 2.0000 | 1.3333 | 1.3333 | 0.0000 | 3.0000 | 0.0000 | 1.0000 | 3.3333 | 2.3333 | 0.0000 | 3.0000 | 1.3333 | 0.3333 |
| HSS9 | 2.3333 | 2.0000 | 1.6667 | 2.3333 | 1.0000 | 0.3333 | 0.6667 | 0.3333 | 0.0000 | 1.3333 | 1.3333 | 2.3333 | 0.6667 | 0.0000 | 0.6667 | 0.6667 | 0.3333 |
| HSS10 | 1.6667 | 0.6667 | 2.3333 | 0.3333 | 2.3333 | 0.0000 | 0.0000 | 0.3333 | 2.0000 | 0.0000 | 0.3333 | 1.0000 | 1.6667 | 0.3333 | 1.3333 | 0.0000 | 0.6667 |
| HSS11 | 0.6667 | 0.6667 | 0.0000 | 0.6667 | 0.0000 | 0.0000 | 0.0000 | 1.3333 | 3.6667 | 1.3333 | 0.0000 | 1.3333 | 0.6667 | 1.6667 | 0.0000 | 0.0000 | 1.6667 |
| HSS12 | 0.6667 | 0.0000 | 1.3333 | 0.0000 | 1.6667 | 1.6667 | 1.0000 | 1.6667 | 4.0000 | 0.0000 | 0.3333 | 0.0000 | 3.3333 | 0.0000 | 1.3333 | 0.0000 | 0.0000 |
| HSS13 | 2.3333 | 0.3333 | 1.6667 | 0.3333 | 2.0000 | 0.3333 | 0.6667 | 1.6667 | 3.3333 | 0.3333 | 0.3333 | 3.6667 | 0.0000 | 0.0000 | 1.6667 | 0.0000 | 0.0000 |
| HSS14 | 0.6667 | 0.3333 | 0.0000 | 1.0000 | 0.0000 | 3.0000 | 0.0000 | 0.0000 | 4.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| HSS15 | 2.0000 | 0.3333 | 1.6667 | 0.0000 | 2.6667 | 2.6667 | 0.6667 | 0.6667 | 4.0000 | 0.0000 | 0.0000 | 0.6667 | 1.3000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| HSS16 | 1.3333 | 0.0000 | 1.3333 | 1.0000 | 1.6667 | 1.3333 | 0.3333 | 0.0000 | 2.3333 | 0.3333 | 0.0000 | 0.6667 | 0.3333 | 1.3333 | 0.6667 | 0.0000 | 0.0000 |
| HSS17 | 1.6667 | 1.6667 | 0.3333 | 0.6667 | 1.0000 | 0.6667 | 0.0000 | 0.0000 | 2.6667 | 0.6667 | 0.3333 | 0.6667 | 0.3333 | 0.0000 | 0.3333 | 0.0000 | 0.0000 |
Normalized direct-relation matrix M.
| HSS1 | HSS2 | HSS3 | HSS4 | HSS5 | HSS6 | HSS7 | HSS8 | HSS9 | HSS10 | HSS11 | HSS12 | HSS13 | HSS14 | HSS15 | HSS16 | HSS17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HSS1 | 0.0000 | 0.0123 | 0.0741 | 0.0370 | 0.0556 | 0.0556 | 0.0679 | 0.0247 | 0.0741 | 0.0247 | 0.0432 | 0.0741 | 0.0494 | 0.0617 | 0.0556 | 0.0123 | 0.0370 |
| HSS2 | 0.0432 | 0.0000 | 0.0123 | 0.0247 | 0.0185 | 0.0123 | 0.0123 | 0.0062 | 0.0309 | 0.0309 | 0.0247 | 0.0309 | 0.0185 | 0.0370 | 0.0123 | 0.0247 | 0.0062 |
| HSS3 | 0.0123 | 0.0000 | 0.0000 | 0.0123 | 0.0741 | 0.0000 | 0.0247 | 0.0062 | 0.0741 | 0.0062 | 0.0185 | 0.0494 | 0.0123 | 0.0000 | 0.0309 | 0.0000 | 0.0062 |
| HSS4 | 0.0062 | 0.0000 | 0.0247 | 0.0000 | 0.0123 | 0.0000 | 0.0062 | 0.0000 | 0.0679 | 0.0000 | 0.0247 | 0.0123 | 0.0000 | 0.0185 | 0.0000 | 0.0000 | 0.0062 |
| HSS5 | 0.0123 | 0.0000 | 0.0247 | 0.0062 | 0.0000 | 0.0247 | 0.0370 | 0.0309 | 0.0741 | 0.0062 | 0.0123 | 0.0741 | 0.0309 | 0.0000 | 0.0370 | 0.0000 | 0.0123 |
| HSS6 | 0.0062 | 0.0000 | 0.0000 | 0.0000 | 0.0185 | 0.0000 | 0.0000 | 0.0123 | 0.0741 | 0.0000 | 0.0000 | 0.0062 | 0.0062 | 0.0000 | 0.0494 | 0.0000 | 0.0000 |
| HSS7 | 0.0123 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0062 | 0.0000 | 0.0309 | 0.0679 | 0.0000 | 0.0000 | 0.0247 | 0.0062 | 0.0000 | 0.0432 | 0.0000 | 0.0000 |
| HSS8 | 0.0494 | 0.0062 | 0.0247 | 0.0062 | 0.0370 | 0.0247 | 0.0247 | 0.0000 | 0.0556 | 0.0000 | 0.0185 | 0.0617 | 0.0432 | 0.0000 | 0.0556 | 0.0247 | 0.0062 |
| HSS9 | 0.0432 | 0.0370 | 0.0309 | 0.0432 | 0.0185 | 0.0062 | 0.0123 | 0.0062 | 0.0000 | 0.0247 | 0.0247 | 0.0432 | 0.0123 | 0.0000 | 0.0123 | 0.0123 | 0.0062 |
| HSS10 | 0.0309 | 0.0123 | 0.0432 | 0.0062 | 0.0432 | 0.0000 | 0.0000 | 0.0062 | 0.0370 | 0.0000 | 0.0062 | 0.0185 | 0.0309 | 0.0062 | 0.0247 | 0.0000 | 0.0123 |
| HSS11 | 0.0123 | 0.0123 | 0.0000 | 0.0123 | 0.0000 | 0.0000 | 0.0000 | 0.0247 | 0.0679 | 0.0247 | 0.0000 | 0.0247 | 0.0123 | 0.0309 | 0.0000 | 0.0000 | 0.0309 |
| HSS12 | 0.0123 | 0.0000 | 0.0247 | 0.0000 | 0.0309 | 0.0309 | 0.0185 | 0.0309 | 0.0741 | 0.0000 | 0.0062 | 0.0000 | 0.0617 | 0.0000 | 0.0247 | 0.0000 | 0.0000 |
| HSS13 | 0.0432 | 0.0062 | 0.0309 | 0.0062 | 0.0370 | 0.0062 | 0.0123 | 0.0309 | 0.0617 | 0.0062 | 0.0062 | 0.0679 | 0.0000 | 0.0000 | 0.0309 | 0.0000 | 0.0000 |
| HSS14 | 0.0123 | 0.0062 | 0.0000 | 0.0185 | 0.0000 | 0.0556 | 0.0000 | 0.0000 | 0.0741 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| HSS15 | 0.0370 | 0.0062 | 0.0309 | 0.0000 | 0.0494 | 0.0494 | 0.0123 | 0.0123 | 0.0741 | 0.0000 | 0.0000 | 0.0123 | 0.0241 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| HSS16 | 0.0247 | 0.0000 | 0.0247 | 0.0185 | 0.0309 | 0.0247 | 0.0062 | 0.0000 | 0.0432 | 0.0062 | 0.0000 | 0.0123 | 0.0062 | 0.0247 | 0.0123 | 0.0000 | 0.0000 |
| HSS17 | 0.0309 | 0.0309 | 0.0062 | 0.0123 | 0.0185 | 0.0123 | 0.0000 | 0.0000 | 0.0494 | 0.0123 | 0.0062 | 0.0123 | 0.0062 | 0.0000 | 0.0062 | 0.0000 | 0.0000 |
Total-relation matrix T.
| HSS1 | HSS2 | HSS3 | HSS4 | HSS5 | HSS6 | HSS7 | HSS8 | HSS9 | HSS10 | HSS11 | HSS12 | HSS13 | HSS14 | HSS15 | HSS16 | HSS17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HSS1 | 0.0244 | 0.0217 | 0.0940 | 0.0497 | 0.0829 | 0.0740 | 0.0822 | 0.0409 | 0.1373 | 0.0329 | 0.0545 | 0.1073 | 0.0697 | 0.0672 | 0.0804 | 0.0159 | 0.0432 |
| HSS2 | 0.0538 | 0.0048 | 0.0253 | 0.0322 | 0.0322 | 0.0230 | 0.0209 | 0.0136 | 0.0607 | 0.0354 | 0.0313 | 0.0473 | 0.0294 | 0.0430 | 0.0243 | 0.0266 | 0.0108 |
| HSS3 | 0.0240 | 0.0053 | 0.0122 | 0.0192 | 0.0851 | 0.0094 | 0.0337 | 0.0153 | 0.1010 | 0.0109 | 0.0249 | 0.0678 | 0.0245 | 0.0029 | 0.0426 | 0.0021 | 0.0100 |
| HSS4 | 0.0125 | 0.0040 | 0.0299 | 0.0055 | 0.0185 | 0.0041 | 0.0101 | 0.0036 | 0.0804 | 0.0036 | 0.0285 | 0.0216 | 0.0048 | 0.0205 | 0.0050 | 0.0013 | 0.0085 |
| HSS5 | 0.0268 | 0.0059 | 0.0376 | 0.0136 | 0.0165 | 0.0347 | 0.0458 | 0.0402 | 0.1053 | 0.0109 | 0.0192 | 0.0924 | 0.0444 | 0.0029 | 0.0516 | 0.0028 | 0.0155 |
| HSS6 | 0.0144 | 0.0040 | 0.0076 | 0.0049 | 0.0262 | 0.0059 | 0.0048 | 0.0160 | 0.0864 | 0.0030 | 0.0039 | 0.0163 | 0.0122 | 0.0013 | 0.0548 | 0.0017 | 0.0018 |
| HSS7 | 0.0214 | 0.0041 | 0.0084 | 0.0051 | 0.0093 | 0.0129 | 0.0054 | 0.0349 | 0.0825 | 0.0030 | 0.0044 | 0.0353 | 0.0139 | 0.0018 | 0.0503 | 0.0022 | 0.0019 |
| HSS8 | 0.0645 | 0.0122 | 0.0418 | 0.0154 | 0.0568 | 0.0387 | 0.0373 | 0.0119 | 0.0947 | 0.0063 | 0.0270 | 0.0855 | 0.0588 | 0.0063 | 0.0725 | 0.0273 | 0.0113 |
| HSS9 | 0.0534 | 0.0404 | 0.0433 | 0.0496 | 0.0333 | 0.0152 | 0.0216 | 0.0140 | 0.0304 | 0.0296 | 0.0322 | 0.0600 | 0.0243 | 0.0072 | 0.0244 | 0.0147 | 0.0110 |
| HSS10 | 0.0410 | 0.0165 | 0.0540 | 0.0127 | 0.0567 | 0.0086 | 0.0092 | 0.0133 | 0.0622 | 0.0045 | 0.0128 | 0.0367 | 0.0406 | 0.0100 | 0.0357 | 0.0020 | 0.0160 |
| HSS11 | 0.0228 | 0.0178 | 0.0092 | 0.0191 | 0.0095 | 0.0070 | 0.0053 | 0.0287 | 0.0855 | 0.0287 | 0.0056 | 0.0365 | 0.0202 | 0.0337 | 0.0078 | 0.0025 | 0.0333 |
| HSS12 | 0.0256 | 0.0052 | 0.0361 | 0.0071 | 0.0446 | 0.0384 | 0.0268 | 0.0387 | 0.0996 | 0.0046 | 0.0126 | 0.0206 | 0.0707 | 0.0024 | 0.0382 | 0.0026 | 0.0031 |
| HSS13 | 0.0557 | 0.0114 | 0.0453 | 0.0142 | 0.0536 | 0.0179 | 0.0240 | 0.0400 | 0.0927 | 0.0113 | 0.0145 | 0.0882 | 0.0154 | 0.0047 | 0.0458 | 0.0031 | 0.0046 |
| HSS14 | 0.0180 | 0.0098 | 0.0055 | 0.0234 | 0.0055 | 0.0581 | 0.0032 | 0.0026 | 0.0847 | 0.0031 | 0.0040 | 0.0074 | 0.0036 | 0.0021 | 0.0061 | 0.0016 | 0.0017 |
| HSS15 | 0.0477 | 0.0112 | 0.0425 | 0.0079 | 0.0625 | 0.0572 | 0.0221 | 0.0202 | 0.1000 | 0.0051 | 0.0074 | 0.0324 | 0.0343 | 0.0038 | 0.0146 | 0.0026 | 0.0040 |
| HSS16 | 0.0317 | 0.0034 | 0.0329 | 0.0240 | 0.0401 | 0.0316 | 0.0126 | 0.0050 | 0.0633 | 0.0093 | 0.0051 | 0.0247 | 0.0131 | 0.0275 | 0.0211 | 0.0014 | 0.0027 |
| HSS17 | 0.0385 | 0.0344 | 0.0149 | 0.0183 | 0.0271 | 0.0180 | 0.0062 | 0.0046 | 0.0653 | 0.0167 | 0.0118 | 0.0244 | 0.0134 | 0.0045 | 0.0139 | 0.0022 | 0.0032 |
Color: values are above the threshold 0.0272.
Influences received and given by each HSS.
| ri | ci | ri + ci | ri − ci | |
|---|---|---|---|---|
| HSS1 | 1.0782 | 0.5760 | 1.6542 | 0.5021 |
| HSS2 | 0.5146 | 0.2121 | 0.7267 | 0.3025 |
| HSS3 | 0.4910 | 0.5407 | 1.0317 | −0.0498 |
| HSS4 | 0.2624 | 0.3219 | 0.5843 | −0.0595 |
| HSS5 | 0.5662 | 0.6606 | 1.2268 | −0.0944 |
| HSS6 | 0.2654 | 0.4546 | 0.7200 | −0.1892 |
| HSS7 | 0.2969 | 0.3712 | 0.6681 | −0.0743 |
| HSS8 | 0.6681 | 0.3435 | 1.0116 | 0.3246 |
| HSS9 | 0.5047 | 1.4320 | 1.9367 | −0.9272 |
| HSS10 | 0.4325 | 0.2189 | 0.6515 | 0.2136 |
| HSS11 | 0.3731 | 0.2998 | 0.6729 | 0.0733 |
| HSS12 | 0.4769 | 0.8044 | 1.2814 | −0.3275 |
| HSS13 | 0.5423 | 0.4935 | 1.0358 | 0.0488 |
| HSS14 | 0.2401 | 0.2418 | 0.4819 | −0.0016 |
| HSS15 | 0.4756 | 0.5891 | 1.0647 | −0.1135 |
| HSS16 | 0.3495 | 0.1126 | 0.4621 | 0.2370 |
| HSS17 | 0.3176 | 0.1825 | 0.5001 | 0.1351 |
Figure 6Influential relation map.